TY - JOUR
T1 - Engaging stakeholders to level up COPD care in LMICs
T2 - lessons learned from the "Breathe Well" programme in Brazil, China, Georgia, and North Macedonia
AU - Fernandes, Genevie
AU - Williams, Siân
AU - Adab, Peymané
AU - Gale, Nicola
AU - de Jong, Corina
AU - de Sousa, Jaime Correia
AU - Cheng, K K
AU - Chi, Chunhua
AU - Cooper, Brendan G
AU - Dickens, Andrew P
AU - Enocson, Alexandra
AU - Farley, Amanda
AU - Jolly, Kate
AU - Jowett, Sue
AU - Maglakelidze, Maka
AU - Maghlakelidze, Tamaz
AU - Martins, Sonia
AU - Sitch, Alice
AU - Stamenova, Aleksandra
AU - Stavrikj, Katarina
AU - Stelmach, Rafael
AU - Turner, Alice
AU - Pan, Zihan
AU - Pang, Hui
AU - Zhang, Jianxin
AU - Jordan, Rachel E
N1 - © 2024. The Author(s).
This research was funded by the National Institute for Health and Care Research (NIHR) NIHR global group on global COPD in primary care, University of Birmingham, (project reference: 16/137/95) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.
PY - 2024/1/12
Y1 - 2024/1/12
N2 - BACKGROUND: Effective stakeholder engagement in health research is increasingly being recognised and promoted as an important pathway to closing the gap between knowledge production and its use in health systems. However, little is known about its process and impacts, particularly in low-and middle-income countries. This opinion piece draws on the stakeholder engagement experiences from a global health research programme on Chronic Obstructive Pulmonary Disease (COPD) led by clinician researchers in Brazil, China, Georgia and North Macedonia, and presents the process, outcomes and lessons learned.MAIN BODY: Each country team was supported with an overarching engagement protocol and mentored to develop a tailored plan. Patient involvement in research was previously limited in all countries, requiring intensive efforts through personal communication, meetings, advisory groups and social media. Accredited training programmes were effective incentives for participation from healthcare providers; and aligning research findings with competing policy priorities enabled interest and dialogue with decision-makers. The COVID-19 pandemic severely limited possibilities for planned engagement, although remote methods were used where possible. Planned and persistent engagement contributed to shared knowledge and commitment to change, including raised patient and public awareness about COPD, improved skills and practice of healthcare providers, increased interest and support from clinical leaders, and dialogue for integrating COPD services into national policy and practice.CONCLUSION: Stakeholder engagement enabled relevant local actors to produce and utilise knowledge for small wins such as improving day-to-day practice and for long-term goals of equitable access to COPD care. For it to be successful and sustained, stakeholder engagement needs to be valued and integrated throughout the research and knowledge generation process, complete with dedicated resources, contextualised and flexible planning, and commitment.
AB - BACKGROUND: Effective stakeholder engagement in health research is increasingly being recognised and promoted as an important pathway to closing the gap between knowledge production and its use in health systems. However, little is known about its process and impacts, particularly in low-and middle-income countries. This opinion piece draws on the stakeholder engagement experiences from a global health research programme on Chronic Obstructive Pulmonary Disease (COPD) led by clinician researchers in Brazil, China, Georgia and North Macedonia, and presents the process, outcomes and lessons learned.MAIN BODY: Each country team was supported with an overarching engagement protocol and mentored to develop a tailored plan. Patient involvement in research was previously limited in all countries, requiring intensive efforts through personal communication, meetings, advisory groups and social media. Accredited training programmes were effective incentives for participation from healthcare providers; and aligning research findings with competing policy priorities enabled interest and dialogue with decision-makers. The COVID-19 pandemic severely limited possibilities for planned engagement, although remote methods were used where possible. Planned and persistent engagement contributed to shared knowledge and commitment to change, including raised patient and public awareness about COPD, improved skills and practice of healthcare providers, increased interest and support from clinical leaders, and dialogue for integrating COPD services into national policy and practice.CONCLUSION: Stakeholder engagement enabled relevant local actors to produce and utilise knowledge for small wins such as improving day-to-day practice and for long-term goals of equitable access to COPD care. For it to be successful and sustained, stakeholder engagement needs to be valued and integrated throughout the research and knowledge generation process, complete with dedicated resources, contextualised and flexible planning, and commitment.
KW - Humans
KW - Developing Countries
KW - Georgia
KW - Brazil
KW - Republic of North Macedonia
KW - Pandemics
U2 - 10.1186/s12913-023-10525-4
DO - 10.1186/s12913-023-10525-4
M3 - Article
C2 - 38216986
SN - 1472-6963
VL - 24
SP - 66
JO - BMC Health Services Research
JF - BMC Health Services Research
IS - 1
ER -